Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 14, 2015; 21(46): 13020-13029
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13020
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13020
Score | Weight loss (%) | Stool consistency | Occult/gross bleeding |
0 | None | Normal | Negative |
1 | 1-5 | ||
2 | 5-10 | Loose stool | |
3 | 10-20 | ||
4 | > 20 | Diarrhea | Gross bleeding |
Mucosal epithelium | |
Ulceration; none (0); mild surface (1); moderate (2); extensive-full thickness (3) | |
Crypts | |
Mitotic activity; lower third (0); mild mid-third (1); moderate mid-third (2); upper third (3) | |
Neutrophilic infiltrate | |
Mucus depletion | |
Lamina propria | |
Plasmacytoid infiltrate | |
Neutrophilic infiltrate | |
Vascularity | |
Fibrin deposition | |
None (0); mucosal (1); submucosal (2); transmural (3) | |
Submucosal | |
Neutrophilic infiltrate | |
Edema |
Groups | Colon weight (g) | Colon length (cm) |
Normal control | 1.48 ± 0.02 | 17.38 ± 0.17 |
Kefir-control | 1.51 ± 0.02 | 17.44 ± 0.18a |
Colitis | 1.58 ± 0.04 | 16.70 ± 0.21 |
Kefir-colitis | 1.65 ± 0.09 | 16.83 ± 0.16 |
- Citation: Senol A, Isler M, Sutcu R, Akin M, Cakir E, Ceyhan BM, Kockar MC. Kefir treatment ameliorates dextran sulfate sodium-induced colitis in rats. World J Gastroenterol 2015; 21(46): 13020-13029
- URL: https://www.wjgnet.com/1007-9327/full/v21/i46/13020.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i46.13020